Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Measuring atopic eczema symptoms in clinical practice: The First Consensus Statement from the Harmonising Outcome Measures for Eczema in Clinical Practice Initiative.

Leshem YA, Chalmers J, Apfelbacher C, Furue M, Gerbens LA, Prinsen CA, Schmitt J, Spuls PI, Thomas KS, Williams HC, Simpson EL; Harmonising Outcome Measures for Eczema (HOME) initiative.

J Am Acad Dermatol. 2020 Jan 8. pii: S0190-9622(20)30029-3. doi: 10.1016/j.jaad.2019.12.055. [Epub ahead of print]

PMID:
31926221
2.

Outcome measurement instruments for peripheral vascular malformations and an assessment of the measurement properties: a systematic review.

Horbach SER, Rongen APM, Elbers RG, van der Horst CMAM, Prinsen CAC, Spuls PI; Collaborators OVAMA consensus group.

Qual Life Res. 2020 Jan;29(1):1-17. doi: 10.1007/s11136-019-02301-x. Epub 2019 Sep 23. Review.

3.

A systematic review of outcome reporting in laser treatments for dermatological diseases.

Fransen F, Tio DCKS, Prinsen CAC, Haedersdal M, Hedelund L, Laubach HJ, Marini L, Paasch U, Passeron T, Wolkerstorfer A.

J Eur Acad Dermatol Venereol. 2020 Jan;34(1):47-53. doi: 10.1111/jdv.15928. Epub 2019 Oct 10. Review.

PMID:
31469447
4.

Performance properties of health-related measurement instruments in whiplash: systematic review protocol.

Abedi A, Prinsen CAC, Shah I, Buser Z, Wang JC.

Syst Rev. 2019 Aug 9;8(1):199. doi: 10.1186/s13643-019-1119-0.

5.

Clinical visible signs of disease activity in vitiligo: a systematic review and meta-analysis.

van Geel N, Grine L, De Wispelaere P, Mertens D, Prinsen CAC, Speeckaert R.

J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1667-1675. doi: 10.1111/jdv.15604. Epub 2019 May 26.

PMID:
31131483
6.

Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer.

Reijnen C, Küsters-Vandevelde HVN, Prinsen CF, Massuger LFAG, Snijders MPML, Kommoss S, Brucker SY, Kwon JS, McAlpine JN, Pijnenborg JMA.

Gynecol Oncol. 2019 Jul;154(1):124-130. doi: 10.1016/j.ygyno.2019.03.097. Epub 2019 May 15.

PMID:
31103324
7.

Measuring positive health: for now, a bridge too far.

Prinsen CAC, Terwee CB.

Public Health. 2019 May;170:70-77. doi: 10.1016/j.puhe.2019.02.024. Epub 2019 Apr 8.

PMID:
30974374
8.

Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting.

van Geel N, Wolkerstorfer A, Ezzedine K, Pandya AG, Bekkenk M, Grine L, Van Belle S, Lommerts JE, Hamzavi I, Harris JE, Eleftheriadou V, Esmat S, Kang HY, Kumarasinghe P, Lan CE, Parsad D, Raboobee N, Flora Xiang L, Suzuki T, Prinsen CA, Taieb A, Picardo M, Speeckaert R; participants of the Rome International VGICC /VIS Workshop.

Pigment Cell Melanoma Res. 2019 Sep;32(5):728-733. doi: 10.1111/pcmr.12784. Epub 2019 May 9.

PMID:
30945409
9.

Navigating the landscape of core outcome set development in dermatology.

Prinsen CAC, Spuls PI, Kottner J, Thomas KS, Apfelbacher C, Chalmers JR, Deckert S, Furue M, Gerbens L, Kirkham J, Simpson EL, Alam M, Balzer K, Beeckman D, Eleftheriadou V, Ezzedine K, Horbach SER, Ingram JR, Layton AM, Weller K, Wild T, Wolkerstorfer A, Williams HC, Schmitt J.

J Am Acad Dermatol. 2019 Jul;81(1):297-305. doi: 10.1016/j.jaad.2019.03.009. Epub 2019 Mar 13. Review.

PMID:
30878565
10.

Cochrane Reviews and Dermatological Trials Outcome Concordance: Why Core Outcome Sets Could Make Trial Results More Usable.

Schmitt J, Lange T, Kottner J, Prinsen CAC, Weberschock T, Hahnel E, Apfelbacher C, Brandstetter S, Dreher A, Stevens G, Burden-Teh E, Rogers N, Spuls P, Grainge MJ, Williams HC, Jacobi L; Cochrane Skin Core Outcome Set Initiative.

J Invest Dermatol. 2019 May;139(5):1045-1053. doi: 10.1016/j.jid.2018.11.019. Epub 2018 Dec 5.

PMID:
30528825
11.

Measurement properties of the OARSI core set of performance-based measures for hip osteoarthritis: a prospective cohort study on reliability, construct validity and responsiveness in 90 hip osteo-arthritis patients.

Tolk JJ, Janssen RPA, Prinsen CSAC, van der Steen MMC, Bierma Zeinstra SMA, Reijman M.

Acta Orthop. 2019 Feb;90(1):15-20. doi: 10.1080/17453674.2018.1539567. Epub 2018 Nov 19.

12.

Reference method for digital surface measurement of target lesions in vitiligo: a comparative analysis.

van Geel N, Vandendriessche D, Vandersichel E, De Schepper S, Grine L, Mertens L, Vandaele V, Spoelders F, Bekkenk M, Wolkerstorfer A, Prinsen CA, Speeckaert R.

Br J Dermatol. 2019 May;180(5):1198-1205. doi: 10.1111/bjd.17190. Epub 2018 Nov 13.

PMID:
30207606
13.

Recommendations on the most suitable quality-of-life measurement instruments for bariatric and body contouring surgery: a systematic review.

de Vries CEE, Kalff MC, Prinsen CAC, Coulman KD, den Haan C, Welbourn R, Blazeby JM, Morton JM, van Wagensveld BA.

Obes Rev. 2018 Oct;19(10):1395-1411. doi: 10.1111/obr.12710. Epub 2018 Jun 8.

PMID:
29883059
14.

Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient-Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative.

Grinich EE, Schmitt J, Küster D, Spuls PI, Williams HC, Chalmers JR, Thomas KS, Apfelbacher C, Prinsen CAC, Furue M, Stuart B, Carter B, Simpson EL.

Br J Dermatol. 2018 Aug;179(2):540-541. doi: 10.1111/bjd.16732. Epub 2018 Jun 25. No abstract available.

PMID:
29747242
15.

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Chalmers JR, Thomas KS, Apfelbacher C, Williams HC, Prinsen CA, Spuls PI, Simpson E, Gerbens LAA, Boers M, Barbarot S, Stalder JF, Abuabara K, Aoki V, Ardeleanu M, Armstrong J, Bang B, Berents TL, Burton T, Butler L, Chubachi T, Cresswell-Melville A, DeLozier A, Eckert L, Eichenfield L, Flohr C, Futamura M, Gadkari A, Gjerde ES, van Halewijn KF, Hawkes C, Howells L, Howie L, Humphreys R, Ishii HA, Kataoka Y, Katayama I, Kouwenhoven W, Langan SM, Leshem YA, Merhand S, Mina-Osorio P, Murota H, Nakahara T, Nunes FP, Nygaard U, Nygårdas M, Ohya Y, Ono E, Rehbinder E, Rogers NK, Romeijn GLE, Schuttelaar MLA, Sears AV, Simpson MA, Singh JA, Srour J, Stuart B, Svensson Å, Talmo G, Talmo H, Teixeira HD, Thyssen JP, Todd G, Torchet F, Volke A, von Kobyletzki L, Weisshaar E, Wollenberg A, Zaniboni M.

Br J Dermatol. 2018 May;178(5):e332-e341. doi: 10.1111/bjd.16543. Epub 2018 Apr 19.

PMID:
29672835
16.

By using a core outcome set we measure what matters to patients.

Prinsen CAC, Spuls PI, Terwee CB.

Br J Dermatol. 2018 Mar;178(3):579-580. doi: 10.1111/bjd.16273. No abstract available.

PMID:
29595219
17.

COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study.

Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, Bouter LM, de Vet HCW, Mokkink LB.

Qual Life Res. 2018 May;27(5):1159-1170. doi: 10.1007/s11136-018-1829-0. Epub 2018 Mar 17.

18.

Whole-exome sequencing of a meningeal melanocytic tumour reveals activating CYSLTR2 and EIF1AX hotspot mutations and similarities to uveal melanoma.

Küsters-Vandevelde HVN, Germans MR, Rabbie R, Rashid M, Ten Broek R, Blokx WAM, Prinsen CFM, Adams DJ, Ter Laan M.

Brain Tumor Pathol. 2018 Apr;35(2):127-130. doi: 10.1007/s10014-018-0308-1. Epub 2018 Feb 23. No abstract available.

PMID:
29476293
19.

COSMIN guideline for systematic reviews of patient-reported outcome measures.

Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, Terwee CB.

Qual Life Res. 2018 May;27(5):1147-1157. doi: 10.1007/s11136-018-1798-3. Epub 2018 Feb 12.

20.

Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members.

Tio D, Prinsen CAC, Dréno B, Hoekzema R, Augustin M, van Montfrans C.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1476-1484. doi: 10.1111/jdv.14850. Epub 2018 Mar 30.

PMID:
29419913
21.

T-QoL: a quality of life outcome measure specifically developed for adolescents with skin diseases.

Prinsen CAC.

Br J Dermatol. 2018 Jan;178(1):23-25. doi: 10.1111/bjd.16076. No abstract available.

PMID:
29357603
22.

The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo.

van Geel N, Bekkenk M, Lommerts JE, Ezzedine K, Harris J, Hamzavi I, Eleftheriadou V, Picardo M, Taieb A, Prinsen CAC, Wolkerstorfer A, Speeckaert R.

J Am Acad Dermatol. 2018 Aug;79(2):369-371. doi: 10.1016/j.jaad.2017.12.070. Epub 2018 Jan 4. No abstract available.

PMID:
29307645
23.

Interrater and intrarater agreement of confocal microscopy imaging in diagnosing and subtyping basal cell carcinoma.

Kadouch DJ, van Haersma de With ASE, Elshot YS, Peppelman M, Bekkenk MW, Wolkerstorfer A, Eekhout I, Prinsen CAC, de Rie MA.

J Eur Acad Dermatol Venereol. 2018 Aug;32(8):1278-1283. doi: 10.1111/jdv.14771. Epub 2018 Jan 23.

24.

COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures.

Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, Terwee CB.

Qual Life Res. 2018 May;27(5):1171-1179. doi: 10.1007/s11136-017-1765-4. Epub 2017 Dec 19.

25.

Validation study of the Vitiligo Extent Score-plus.

van Geel N, Wolkerstorfer A, Lommerts JE, Ezzedine K, Eleftheriadou V, Hamzavi I, Harris J, Picardo M, Taieb A, Prinsen CAC, Bekkenk M, Speeckaert R.

J Am Acad Dermatol. 2018 May;78(5):1013-1015. doi: 10.1016/j.jaad.2017.11.032. Epub 2017 Nov 24. No abstract available.

PMID:
29180094
26.

The OARSI core set of performance-based measures for knee osteoarthritis is reliable but not valid and responsive.

Tolk JJ, Janssen RPA, Prinsen CAC, Latijnhouwers DAJM, van der Steen MC, Bierma-Zeinstra SMA, Reijman M.

Knee Surg Sports Traumatol Arthrosc. 2019 Sep;27(9):2898-2909. doi: 10.1007/s00167-017-4789-y. Epub 2017 Nov 11.

PMID:
29128879
27.

Changing patients' understanding of psoriasis is promising.

Prinsen CAC.

Br J Dermatol. 2017 Sep;177(3):616-617. doi: 10.1111/bjd.15760. No abstract available.

PMID:
28940284
28.

The COMET Handbook: version 1.0.

Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, Clarke M, Gargon E, Gorst S, Harman N, Kirkham JJ, McNair A, Prinsen CAC, Schmitt J, Terwee CB, Young B.

Trials. 2017 Jun 20;18(Suppl 3):280. doi: 10.1186/s13063-017-1978-4. Review.

29.

Meeting report: Vitiligo Global Issues Consensus Conference Workshop "Outcome measurement instruments" and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd.

van Geel N, Boniface K, Seneschal J, Jacquemin C, Speeckaert R, Wolkerstorfer A, Bekkenk M, Lommerts JE, Hamzavi I, Pandya A, Eleftheriadou V, Ezzedine K, Giannarelli D, Gnarra M, Sperduti I, Prinsen C, Harris J, Taieb A, Picardo M.

Pigment Cell Melanoma Res. 2017 Jul;30(4):436-443. doi: 10.1111/pcmr.12593. Epub 2017 Jun 13. No abstract available.

PMID:
28379638
30.

Norwegian translation, and validation, of the Pelvic Floor Distress Inventory (PFDI-20) and the Pelvic Floor Impact Questionnaire (PFIQ-7).

Teig CJ, Grotle M, Bond MJ, Prinsen CAC, Engh MAE, Cvancarova MS, Kjøllesdal M, Martini A.

Int Urogynecol J. 2017 Jul;28(7):1005-1017. doi: 10.1007/s00192-016-3209-z. Epub 2017 Jan 6.

PMID:
28062903
31.

A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.

Tio D, van der Woude J, Prinsen CAC, Jansma EP, Hoekzema R, van Montfrans C.

J Eur Acad Dermatol Venereol. 2017 Apr;31(4):616-624. doi: 10.1111/jdv.14085. Epub 2017 Jan 23. Review.

PMID:
27987308
32.

Development and validation of a patient-reported outcome measure in vitiligo: The Self Assessment Vitiligo Extent Score (SA-VES).

van Geel N, Lommerts JE, Bekkenk MW, Prinsen CA, Eleftheriadou V, Taieb A, Picardo M, Ezzedine K, Wolkerstorfer A, Speeckaert R; international Vitiligo Score Working Group.

J Am Acad Dermatol. 2017 Mar;76(3):464-471. doi: 10.1016/j.jaad.2016.09.034. Epub 2016 Nov 22.

PMID:
27887798
33.

Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.

Spuls PI, Gerbens LAA, Simpson E, Apfelbacher CJ, Chalmers JR, Thomas KS, Prinsen CAC, von Kobyletzki LB, Singh JA, Williams HC, Schmitt J; HOME initiative collaborators.

Br J Dermatol. 2017 Apr;176(4):979-984. doi: 10.1111/bjd.15179. Epub 2017 Mar 2. Review.

PMID:
27858989
34.

Why quality of life measurement is important in dermatology clinical practice: An expert-based opinion statement by the EADV Task Force on Quality of Life.

Finlay AY, Salek MS, Abeni D, Tomás-Aragonés L, van Cranenburgh OD, Evers AW, Jemec GB, Linder D, Manolache L, Marrón SE, Prinsen CA, Susitaival P, Chernyshov PV; EADV Task Force on Quality of Life.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):424-431. doi: 10.1111/jdv.13985. Epub 2016 Oct 24. Review.

PMID:
27684717
35.

Patients with lichen sclerosus experience moderate satisfaction with treatment and impairment of quality of life: results of a cross-sectional study.

van Cranenburgh OD, Nijland SBW, Lindeboom R, de Korte J, de Rie MA, Ter Stege JA, Prinsen CAC.

Br J Dermatol. 2017 Jun;176(6):1508-1515. doi: 10.1111/bjd.15125. Epub 2017 Mar 21.

PMID:
27718500
36.

How to select outcome measurement instruments for outcomes included in a "Core Outcome Set" - a practical guideline.

Prinsen CA, Vohra S, Rose MR, Boers M, Tugwell P, Clarke M, Williamson PR, Terwee CB.

Trials. 2016 Sep 13;17(1):449. doi: 10.1186/s13063-016-1555-2.

37.

Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review.

Heinl D, Prinsen CAC, Sach T, Drucker AM, Ofenloch R, Flohr C, Apfelbacher C.

Br J Dermatol. 2017 Apr;176(4):878-889. doi: 10.1111/bjd.14966. Epub 2017 Feb 16. Review.

PMID:
27543747
38.

DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.

Hubers AJ, Heideman DA, Duin S, Witte BI, de Koning HJ, Groen HJ, Prinsen CF, Bolijn AS, Wouters M, van der Meer SE, Steenbergen RD, Snijders PJ, Uyterlinde A, Berkhof H, Smit EF, Thunnissen E.

J Clin Pathol. 2017 Mar;70(3):250-254. doi: 10.1136/jclinpath-2016-203734. Epub 2016 Aug 5.

PMID:
27496969
39.

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Chalmers JR, Simpson E, Apfelbacher CJ, Thomas KS, von Kobyletzki L, Schmitt J, Singh JA, Svensson Å, Williams HC, Abuabara K, Aoki V, Ardeleanu M, Awici-Rasmussen M, Barbarot S, Berents TL, Block J, Bragg A, Burton T, Bjerring Clemmensen KK, Creswell-Melville A, Dinesen M, Drucker A, Eckert L, Flohr C, Garg M, Gerbens LA, Graff AL, Hanifin J, Heinl D, Humphreys R, Ishii HA, Kataoka Y, Leshem YA, Marquort B, Massuel MA, Merhand S, Mizutani H, Murota H, Murrell DF, Nakahara T, Nasr I, Nograles K, Ohya Y, Osterloh I, Pander J, Prinsen C, Purkins L, Ridd M, Sach T, Schuttelaar ML, Shindo S, Smirnova J, Sulzer A, Synnøve Gjerde E, Takaoka R, Vestby Talmo H, Tauber M, Torchet F, Volke A, Wahlgren CF, Weidinger S, Weisshaar E, Wollenberg A, Yamaga K, Zhao CY, Spuls PI.

Br J Dermatol. 2016 Jul;175(1):69-79. doi: 10.1111/bjd.14773. Epub 2016 Jul 19.

PMID:
27436240
40.

Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review.

Gerbens LA, Prinsen CA, Chalmers JR, Drucker AM, von Kobyletzki LB, Limpens J, Nankervis H, Svensson Å, Terwee CB, Zhang J, Apfelbacher CJ, Spuls PI; Harmonising Outcome Measures for Eczema (HOME) initiative.

Allergy. 2017 Jan;72(1):146-163. doi: 10.1111/all.12959. Epub 2016 Jul 13. Review.

PMID:
27322918
41.

Optimising size and depth of punch grafts in autologous transplantation of vitiligo and piebaldism: a randomised controlled trial.

Komen L, Vrijman C, Prinsen CA, van der Veen JP, Luiten RM, Wolkerstorfer A.

J Dermatolog Treat. 2017 Feb;28(1):86-91. doi: 10.1080/09546634.2016.1179251. Epub 2016 Jun 16.

PMID:
27309418
42.

Measuring the impact of skin disease on children's quality of life.

Prinsen CA, Apfelbacher C.

Br J Dermatol. 2016 Apr;174(4):720-1. doi: 10.1111/bjd.14447. No abstract available.

PMID:
27115588
43.

Knee Injury and Osteoarthritis Outcome Score (KOOS): systematic review and meta-analysis of measurement properties.

Collins NJ, Prinsen CA, Christensen R, Bartels EM, Terwee CB, Roos EM.

Osteoarthritis Cartilage. 2016 Aug;24(8):1317-29. doi: 10.1016/j.joca.2016.03.010. Epub 2016 Mar 21. Review.

44.

Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic review.

Heinl D, Prinsen CA, Drucker AM, Ofenloch R, Humphreys R, Sach T, Flohr C, Apfelbacher C.

Syst Rev. 2016 Feb 9;5:25. doi: 10.1186/s13643-016-0202-z.

45.

Development and Validation of the Vitiligo Extent Score (VES): an International Collaborative Initiative.

van Geel N, Lommerts J, Bekkenk M, Wolkerstorfer A, Prinsen CAC, Eleftheriadou V, Taïeb A, Picardo M, Ezzedine K, Speeckaert R.

J Invest Dermatol. 2016 May;136(5):978-984. doi: 10.1016/j.jid.2015.12.040. Epub 2016 Jan 28.

46.

The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) and how to select an outcome measurement instrument.

Mokkink LB, Prinsen CA, Bouter LM, Vet HC, Terwee CB.

Braz J Phys Ther. 2016 Jan 19;20(2):105-13. doi: 10.1590/bjpt-rbf.2014.0143.

47.

Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN).

Schmitt J, Deckert S, Alam M, Apfelbacher C, Barbaric J, Bauer A, Chalmers J, Chosidow O, Delamere F, Doney E, Eleftheriadou V, Grainge M, Johannsen L, Kottner J, Le Cleach L, Mayer A, Pinart M, Prescott L, Prinsen CA, Ratib S, Schlager JG, Sharma M, Thomas KS, Weberschock T, Weller K, Werner RN, Wild T, Wilkes SR, Williams HC.

Br J Dermatol. 2016 Feb;174(2):287-95. doi: 10.1111/bjd.14337. Epub 2016 Jan 18.

PMID:
26779929
48.

Satisfaction with treatment and health-related quality of life among patients with lichen planus: a web-based survey.

Van Cranenburgh OD, Nijland SB, De Korte J, Lindeboom R, De Rie MA, Ter Stege JA, Prinsen CA.

Eur J Dermatol. 2016 Jan-Feb;26(1):113-6. doi: 10.1684/ejd.2015.2703. No abstract available.

PMID:
26771827
49.

SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.

Küsters-Vandevelde HV, Creytens D, van Engen-van Grunsven AC, Jeunink M, Winnepenninckx V, Groenen PJ, Küsters B, Wesseling P, Blokx WA, Prinsen CF.

Acta Neuropathol Commun. 2016 Jan 15;4:5. doi: 10.1186/s40478-016-0272-0.

50.

Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review.

Heinl D, Prinsen CA, Deckert S, Chalmers JR, Drucker AM, Ofenloch R, Humphreys R, Sach T, Chamlin SL, Schmitt J, Apfelbacher C.

Allergy. 2016 Mar;71(3):358-70. doi: 10.1111/all.12806. Epub 2015 Dec 16. Review.

PMID:
26564008

Supplemental Content

Loading ...
Support Center